Page last updated: 2024-11-01

nifedipine and Wiskott-Aldrich Syndrome

nifedipine has been researched along with Wiskott-Aldrich Syndrome in 1 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Wiskott-Aldrich Syndrome: A rare, X-linked immunodeficiency syndrome characterized by ECZEMA; LYMPHOPENIA; and, recurrent pyogenic infection. It is seen exclusively in young boys. Typically, IMMUNOGLOBULIN M levels are low and IMMUNOGLOBULIN A and IMMUNOGLOBULIN E levels are elevated. Lymphoreticular malignancies are common.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liesveld, J1
Duerst, R1
Rapoport, A1
Constine, L1
Abboud, C1
Packman, C1
Wedow, L1
Zwetsch, L1
McKenna, B1
Linder, T1
Silverman, W1
Swift, S1
Rowe, J1
DiPersio, J1

Other Studies

1 other study available for nifedipine and Wiskott-Aldrich Syndrome

ArticleYear
Continuous infusion cyclosporine and nifedipine to day +100 with short methotrexate and steroids as GVHD prophylaxis in unrelated donor transplants.
    Bone marrow transplantation, 1999, Volume: 24, Issue:5

    Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Calcium Channel Blockers; Cause of

1999